Cargando…
Development and evaluation of antibody-capture immunoassays for detection of Lassa virus nucleoprotein-specific immunoglobulin M and G
BACKGROUND: The classical method for detection of Lassa virus-specific antibodies is the immunofluorescence assay (IFA) using virus-infected cells as antigen. However, IFA requires laboratories of biosafety level 4 for assay production and an experienced investigator to interpret the fluorescence si...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5892945/ https://www.ncbi.nlm.nih.gov/pubmed/29596412 http://dx.doi.org/10.1371/journal.pntd.0006361 |
_version_ | 1783313238455222272 |
---|---|
author | Gabriel, Martin Adomeh, Donatus I. Ehimuan, Jacqueline Oyakhilome, Jennifer Omomoh, Emmanuel O. Ighodalo, Yemisi Olokor, Thomas Bonney, Kofi Pahlmann, Meike Emmerich, Petra Lelke, Michaela Brunotte, Linda Ölschläger, Stephan Thomé-Bolduan, Corinna Becker-Ziaja, Beate Busch, Carola Odia, Ikponmwosa Ogbaini-Emovon, Ephraim Okokhere, Peter O. Okogbenin, Sylvanus A. Akpede, George O. Schmitz, Herbert Asogun, Danny A. Günther, Stephan |
author_facet | Gabriel, Martin Adomeh, Donatus I. Ehimuan, Jacqueline Oyakhilome, Jennifer Omomoh, Emmanuel O. Ighodalo, Yemisi Olokor, Thomas Bonney, Kofi Pahlmann, Meike Emmerich, Petra Lelke, Michaela Brunotte, Linda Ölschläger, Stephan Thomé-Bolduan, Corinna Becker-Ziaja, Beate Busch, Carola Odia, Ikponmwosa Ogbaini-Emovon, Ephraim Okokhere, Peter O. Okogbenin, Sylvanus A. Akpede, George O. Schmitz, Herbert Asogun, Danny A. Günther, Stephan |
author_sort | Gabriel, Martin |
collection | PubMed |
description | BACKGROUND: The classical method for detection of Lassa virus-specific antibodies is the immunofluorescence assay (IFA) using virus-infected cells as antigen. However, IFA requires laboratories of biosafety level 4 for assay production and an experienced investigator to interpret the fluorescence signals. Therefore, we aimed to establish and evaluate enzyme-linked immunosorbent assays (ELISA) using recombinant Lassa virus nucleoprotein (NP) as antigen. METHODOLOGY/PRINCIPAL FINDINGS: The IgM ELISA is based on capturing IgM antibodies using anti-IgM, and the IgG ELISA is based on capturing IgG antibody–antigen complexes using rheumatoid factor or Fc gamma receptor CD32a. Analytical and clinical evaluation was performed with 880 sera from Lassa fever endemic (Nigeria) and non-endemic (Ghana and Germany) areas. Using the IFA as reference method, we observed 91.5–94.3% analytical accuracy of the ELISAs in detecting Lassa virus-specific antibodies. Evaluation of the ELISAs for diagnosis of Lassa fever on admission to hospital in an endemic area revealed a clinical sensitivity for the stand-alone IgM ELISA of 31% (95% CI 25–37) and for combined IgM/IgG detection of 26% (95% CI 21–32) compared to RT-PCR. The specificity of IgM and IgG ELISA was estimated at 96% (95% CI 93–98) and 100% (95% CI 99–100), respectively, in non-Lassa fever patients from non-endemic areas. In patients who seroconverted during follow-up, Lassa virus-specific IgM and IgG developed simultaneously rather than sequentially. Consistent with this finding, isolated IgM reactivity, i.e. IgM in the absence of IgG, had no diagnostic value. CONCLUSIONS/SIGNIFICANCE: The ELISAs are not equivalent to RT-PCR for early diagnosis of Lassa fever; however, they are of value in diagnosing patients at later stage. The IgG ELISA may be useful for epidemiological studies and clinical trials due its high specificity, and the higher throughput rate and easier operation compared to IFA. |
format | Online Article Text |
id | pubmed-5892945 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-58929452018-04-20 Development and evaluation of antibody-capture immunoassays for detection of Lassa virus nucleoprotein-specific immunoglobulin M and G Gabriel, Martin Adomeh, Donatus I. Ehimuan, Jacqueline Oyakhilome, Jennifer Omomoh, Emmanuel O. Ighodalo, Yemisi Olokor, Thomas Bonney, Kofi Pahlmann, Meike Emmerich, Petra Lelke, Michaela Brunotte, Linda Ölschläger, Stephan Thomé-Bolduan, Corinna Becker-Ziaja, Beate Busch, Carola Odia, Ikponmwosa Ogbaini-Emovon, Ephraim Okokhere, Peter O. Okogbenin, Sylvanus A. Akpede, George O. Schmitz, Herbert Asogun, Danny A. Günther, Stephan PLoS Negl Trop Dis Research Article BACKGROUND: The classical method for detection of Lassa virus-specific antibodies is the immunofluorescence assay (IFA) using virus-infected cells as antigen. However, IFA requires laboratories of biosafety level 4 for assay production and an experienced investigator to interpret the fluorescence signals. Therefore, we aimed to establish and evaluate enzyme-linked immunosorbent assays (ELISA) using recombinant Lassa virus nucleoprotein (NP) as antigen. METHODOLOGY/PRINCIPAL FINDINGS: The IgM ELISA is based on capturing IgM antibodies using anti-IgM, and the IgG ELISA is based on capturing IgG antibody–antigen complexes using rheumatoid factor or Fc gamma receptor CD32a. Analytical and clinical evaluation was performed with 880 sera from Lassa fever endemic (Nigeria) and non-endemic (Ghana and Germany) areas. Using the IFA as reference method, we observed 91.5–94.3% analytical accuracy of the ELISAs in detecting Lassa virus-specific antibodies. Evaluation of the ELISAs for diagnosis of Lassa fever on admission to hospital in an endemic area revealed a clinical sensitivity for the stand-alone IgM ELISA of 31% (95% CI 25–37) and for combined IgM/IgG detection of 26% (95% CI 21–32) compared to RT-PCR. The specificity of IgM and IgG ELISA was estimated at 96% (95% CI 93–98) and 100% (95% CI 99–100), respectively, in non-Lassa fever patients from non-endemic areas. In patients who seroconverted during follow-up, Lassa virus-specific IgM and IgG developed simultaneously rather than sequentially. Consistent with this finding, isolated IgM reactivity, i.e. IgM in the absence of IgG, had no diagnostic value. CONCLUSIONS/SIGNIFICANCE: The ELISAs are not equivalent to RT-PCR for early diagnosis of Lassa fever; however, they are of value in diagnosing patients at later stage. The IgG ELISA may be useful for epidemiological studies and clinical trials due its high specificity, and the higher throughput rate and easier operation compared to IFA. Public Library of Science 2018-03-29 /pmc/articles/PMC5892945/ /pubmed/29596412 http://dx.doi.org/10.1371/journal.pntd.0006361 Text en © 2018 Gabriel et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Gabriel, Martin Adomeh, Donatus I. Ehimuan, Jacqueline Oyakhilome, Jennifer Omomoh, Emmanuel O. Ighodalo, Yemisi Olokor, Thomas Bonney, Kofi Pahlmann, Meike Emmerich, Petra Lelke, Michaela Brunotte, Linda Ölschläger, Stephan Thomé-Bolduan, Corinna Becker-Ziaja, Beate Busch, Carola Odia, Ikponmwosa Ogbaini-Emovon, Ephraim Okokhere, Peter O. Okogbenin, Sylvanus A. Akpede, George O. Schmitz, Herbert Asogun, Danny A. Günther, Stephan Development and evaluation of antibody-capture immunoassays for detection of Lassa virus nucleoprotein-specific immunoglobulin M and G |
title | Development and evaluation of antibody-capture immunoassays for detection of Lassa virus nucleoprotein-specific immunoglobulin M and G |
title_full | Development and evaluation of antibody-capture immunoassays for detection of Lassa virus nucleoprotein-specific immunoglobulin M and G |
title_fullStr | Development and evaluation of antibody-capture immunoassays for detection of Lassa virus nucleoprotein-specific immunoglobulin M and G |
title_full_unstemmed | Development and evaluation of antibody-capture immunoassays for detection of Lassa virus nucleoprotein-specific immunoglobulin M and G |
title_short | Development and evaluation of antibody-capture immunoassays for detection of Lassa virus nucleoprotein-specific immunoglobulin M and G |
title_sort | development and evaluation of antibody-capture immunoassays for detection of lassa virus nucleoprotein-specific immunoglobulin m and g |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5892945/ https://www.ncbi.nlm.nih.gov/pubmed/29596412 http://dx.doi.org/10.1371/journal.pntd.0006361 |
work_keys_str_mv | AT gabrielmartin developmentandevaluationofantibodycaptureimmunoassaysfordetectionoflassavirusnucleoproteinspecificimmunoglobulinmandg AT adomehdonatusi developmentandevaluationofantibodycaptureimmunoassaysfordetectionoflassavirusnucleoproteinspecificimmunoglobulinmandg AT ehimuanjacqueline developmentandevaluationofantibodycaptureimmunoassaysfordetectionoflassavirusnucleoproteinspecificimmunoglobulinmandg AT oyakhilomejennifer developmentandevaluationofantibodycaptureimmunoassaysfordetectionoflassavirusnucleoproteinspecificimmunoglobulinmandg AT omomohemmanuelo developmentandevaluationofantibodycaptureimmunoassaysfordetectionoflassavirusnucleoproteinspecificimmunoglobulinmandg AT ighodaloyemisi developmentandevaluationofantibodycaptureimmunoassaysfordetectionoflassavirusnucleoproteinspecificimmunoglobulinmandg AT olokorthomas developmentandevaluationofantibodycaptureimmunoassaysfordetectionoflassavirusnucleoproteinspecificimmunoglobulinmandg AT bonneykofi developmentandevaluationofantibodycaptureimmunoassaysfordetectionoflassavirusnucleoproteinspecificimmunoglobulinmandg AT pahlmannmeike developmentandevaluationofantibodycaptureimmunoassaysfordetectionoflassavirusnucleoproteinspecificimmunoglobulinmandg AT emmerichpetra developmentandevaluationofantibodycaptureimmunoassaysfordetectionoflassavirusnucleoproteinspecificimmunoglobulinmandg AT lelkemichaela developmentandevaluationofantibodycaptureimmunoassaysfordetectionoflassavirusnucleoproteinspecificimmunoglobulinmandg AT brunottelinda developmentandevaluationofantibodycaptureimmunoassaysfordetectionoflassavirusnucleoproteinspecificimmunoglobulinmandg AT olschlagerstephan developmentandevaluationofantibodycaptureimmunoassaysfordetectionoflassavirusnucleoproteinspecificimmunoglobulinmandg AT thomebolduancorinna developmentandevaluationofantibodycaptureimmunoassaysfordetectionoflassavirusnucleoproteinspecificimmunoglobulinmandg AT beckerziajabeate developmentandevaluationofantibodycaptureimmunoassaysfordetectionoflassavirusnucleoproteinspecificimmunoglobulinmandg AT buschcarola developmentandevaluationofantibodycaptureimmunoassaysfordetectionoflassavirusnucleoproteinspecificimmunoglobulinmandg AT odiaikponmwosa developmentandevaluationofantibodycaptureimmunoassaysfordetectionoflassavirusnucleoproteinspecificimmunoglobulinmandg AT ogbainiemovonephraim developmentandevaluationofantibodycaptureimmunoassaysfordetectionoflassavirusnucleoproteinspecificimmunoglobulinmandg AT okokherepetero developmentandevaluationofantibodycaptureimmunoassaysfordetectionoflassavirusnucleoproteinspecificimmunoglobulinmandg AT okogbeninsylvanusa developmentandevaluationofantibodycaptureimmunoassaysfordetectionoflassavirusnucleoproteinspecificimmunoglobulinmandg AT akpedegeorgeo developmentandevaluationofantibodycaptureimmunoassaysfordetectionoflassavirusnucleoproteinspecificimmunoglobulinmandg AT schmitzherbert developmentandevaluationofantibodycaptureimmunoassaysfordetectionoflassavirusnucleoproteinspecificimmunoglobulinmandg AT asogundannya developmentandevaluationofantibodycaptureimmunoassaysfordetectionoflassavirusnucleoproteinspecificimmunoglobulinmandg AT guntherstephan developmentandevaluationofantibodycaptureimmunoassaysfordetectionoflassavirusnucleoproteinspecificimmunoglobulinmandg |